Catalyst Pharmaceutical CPRX Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Catalyst Pharmaceutical's income tax?
- Catalyst Pharmaceutical (CPRX) reported income tax of $20.5M in Q1 2026.
- How has Catalyst Pharmaceutical's income tax changed year-over-year?
- Catalyst Pharmaceutical's income tax increased by 40.9% year-over-year, from $14.55M to $20.5M.
- What is the long-term trend for Catalyst Pharmaceutical's income tax?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's income tax has grown at a 51.4% compound annual growth rate (CAGR), from $13.19M to $69.19M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.